Zobrazeno 1 - 10
of 42
pro vyhledávání: '"anti-obesity agent"'
Publikováno v:
BIO Web of Conferences, Vol 86, p 01055 (2024)
The objective of the study was to assess the lipase inhibitory activities of chloroformic, methanolic and aqueous extracts from the commonly available Murraya koenigii (L.) Spreng leaves(Rutaceae) in southern villages of Goa, for potential use in the
Externí odkaz:
https://doaj.org/article/9da7c9eee9454555a5b199283a30ad39
Autor:
Nattapong Wongchum, Ananya Dechakhamphu, Panatda Panya, Somchai Pinlaor, Sitthisak Pinmongkhonkul, Alongklod Tanomtong
Publikováno v:
Journal of HerbMed Pharmacology, Vol 11, Iss 2, Pp 296-304 (2022)
Introduction: Cyperus rotundus L. is suspected of having anti-obesity properties. The purpose of this study was to determine the anti-obesity property of hydroethanolic C. rotundus extract (HECE) using Drosophila as a model organism. Methods: In vitr
Externí odkaz:
https://doaj.org/article/8ca19c28d4514694a4f9c48931c3b86e
Autor:
Faheem Mustafa, Hitesh Chopra, Atif Amin Baig, Satya Kumar Avula, Sony Kumari, Tapan Kumar Mohanta, Muthupandian Saravanan, Awdhesh Kumar Mishra, Nanaocha Sharma, Yugal Kishore Mohanta
Publikováno v:
Journal of Fungi, Vol 8, Iss 2, p 211 (2022)
Obesity, usually indicated by a body mass index of more than 30 kg/m2, is a worsening global health issue. It leads to chronic diseases, including type II diabetes, hypertension, and cardiovascular diseases. Conventional treatments for obesity includ
Externí odkaz:
https://doaj.org/article/04c12066ee074ca0bb1e93388f44e6d4
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 127 (2020)
HSG4112, a racemic drug, is a new anti-obesity agent. In this study, the stereoselective pharmacokinetics of HSG4112 were investigated in rats and dogs, and the underlying mechanism was investigated. The plasma concentrations of HSG4112(S) and HSG411
Externí odkaz:
https://doaj.org/article/f128c33741f24471912c105d81dd1770
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 127 (2020)
Pharmaceutics
Volume 12
Issue 2
Pharmaceutics
Volume 12
Issue 2
HSG4112, a racemic drug, is a new anti-obesity agent. In this study, the stereoselective pharmacokinetics of HSG4112 were investigated in rats and dogs, and the underlying mechanism was investigated. The plasma concentrations of HSG4112(S) and HSG411
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silvia Savastano, Annamaria Colao, Gabriella Pugliese, Luigi Barrea, Giovanna Muscogiuri, Daniela Laudisio
The prevalence of obesity increases worldwide and has a significant economic impact on health care systems. A comprehensive program of lifestyle modification, including diet, exercise, and behavior therapy is considered the first option for achieving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db9e64df38b7a38cfd903d694d2ea6b
http://hdl.handle.net/11588/827680
http://hdl.handle.net/11588/827680
Autor:
Roberto Toraldo, Giuseppina Rosaria Umano, E. Miraglia del Giudice, Anna Grandone, A. Di Sessa
Publikováno v:
Best practiceresearch. Clinical endocrinologymetabolism. 32(4)
The treatment of childhood obesity represents a greater challenge for pediatricians. To date, it is multidisciplinary, including behavioral, dietary, pharmacological, and surgical options. Given the limited efficacy of available treatments, scientifi